PART I INTRODUCTION -- Laboratory Aspects of Medical Mycology -- Epidemiology of Systemic Fungal Diseases: Overview -- PART II SYSTEMIC ANTIFUNGAL DRUGS -- Amphotericin B -- Liposomal Nystatin -- Flucytosine -- Azole Antifungal Drugs -- Cell Wall Synthesis Inhibitors: Echinocandins and Nikkomycins -- Terbinafine -- Resistance to Antifungal Drugs -- Adjunctive Antifungal Therapy -- PART III MYCOSES CAUSED BY YEASTS -- Candidiasis -- Cryptococcosis -- Rhodotorula, Malassezia, Trichosporon, and Other Yeast-Like Fungi -- PART IV MYCOSES CAUSED BY MOULDS -- Aspergillosis -- Zygomycoses -- Hyalohyphomycoses (other than Aspergillosis and Penicilliosis) -- Phaeohyphomycoses -- PART V MYCOSES CAUSED BY DIMORPHIC FUNGI -- Histoplasmosis -- Blastomycosis -- Coccidioidomycosis -- Paracoccidioidomycosis -- Sporotrichosis -- Penicilliosis -- PART VI MYCOLOGY INVOLVING SKIN AND SUBCUTANEOUS TISSUES -- Superficial Cutaneous Fungal Infections -- Eumycetoma -- Chromoblastomycosis -- PART VII OTHER MYCOSES -- Pneumocystosis -- Miscellaneous Fungi -- PART VIII SPECIAL PATIENT POPULATIONS -- Fungal Infections in Neutropenic Patients -- Fungal Infections in Blood and Marrow Transplant Recipients -- Fungal Infections in Solid Organ Transplant Recipients -- Fungal Infections among Patients with AIDS.